文献速递心脑血管急症复苏、休克与脓毒症重症综合管理与镇静镇痛

入院时中性粒细胞明胶酶相关脂质运载蛋白(NGAL)与ST段抬高型心肌梗死患者晚期心源性休克发生及死亡率相关

Neutrophil Gelatinase-Associated Lipocalin (NGAL) Measured at Admission is Associated With Development of Late Cardiogenic Shock and Mortality in Patients With ST-Segment Elevation Myocardial Infarction.
PubMed 文献 · Shock · 2021-01-01
一句话结论STEMI患者入院NGAL浓度独立关联30天全因死亡(HR 3.18)并预测晚期心源性休克(OR 3.64)。

该研究纳入丹麦两家三级心脏中心1年内1,626例连续STEMI患者,在入院造影前测量血浆NGAL浓度并按四分位分组。调整晚期心源性休克风险评分后,NGAL最高四分位组(Q4)与Q1-3相比晚期心源性休克发生风险独立相关(OR 3.64,95%CI 1.79-7.41);调整性别、年龄、PCI后罪犯血管TIMI血流、LVEF、肾功能不全及心脏骤停后昏迷状态后,NGAL与30天全因死亡独立相关(HR 3.18,95%CI 1.73-5.84)。结论提示入院NGAL可帮助识别STEMI后晚期心源性休克高危患者。

要点

  • STEMI患者入院造影前血浆NGAL最高四分位组(Q4)较Q1-3晚期心源性休克风险独立升高(OR 3.64,95%CI 1.79-7.41)。
  • 调整性别、年龄、PCI后罪犯血管TIMI血流、LVEF、肾功能不全及心脏骤停后昏迷后,NGAL与30天全因死亡独立相关(HR 3.18,95%CI 1.73-5.84)。
  • NGAL浓度升高与更高年龄、更多合并症及更危重状态(包括更低血压和LVEF)相关。
  • 研究为观察性设计,NGAL为入院时单次测量,不能据此直接用于临床决策阈值。

适用人群与场景

  • 丹麦两家三级心脏中心连续收治的STEMI患者,入院造影前测量血浆NGAL浓度(1,626/1,892例,86%)。

诊断标准与关键阈值

  • 原文未提及诊断标准或关键阈值;NGAL按四分位(Q1-4)分层分析。
  • 晚期心源性休克定义为离开导管室后发生的心源性休克。

处置流程与药物剂量

  • 原文未提及基于NGAL的具体处置流程或药物剂量。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:观察性队列研究,1,626例STEMI患者,来自丹麦两家三级心脏中心,为期1年。
  • 干预与对照:按入院血浆NGAL四分位分组(Q1-4),无干预对照。
  • 主要终点:晚期心源性休克(离开导管室后发生);调整Observatoire Régional Breton sur l'Infarctus晚期心源性休克风险评分后,Q4 vs Q1-3的OR为3.64(95%CI 1.79-7.41)。
  • 关键次要终点:30天全因死亡;调整性别、年龄、PCI后罪犯血管TIMI血流、LVEF、肾功能不全及心脏骤停后昏迷状态后,HR为3.18(95%CI 1.73-5.84)。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:观察性队列研究(原文未给出证据等级或推荐强度)。
  • 局限:观察性设计,NGAL为入院时单次测量,原文未提及多中心随机对照验证。

对床旁实践的改变

  • 原文提示入院NGAL可能有助于识别STEMI后晚期心源性休克高危患者,但为观察性关联,不能据此确定临床决策阈值或改变常规处置。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

ABSTRACT: In patients with ST-elevation myocardial infarction (STEMI) the immune system is activated with an inflammatory response to follow. In STEMI patients with a severe inflammatory response, risk of development of cardiogenic shock (CS) seems increased. Neutrophil Gelatinase-Associated Lipocalin (NGAL) is a glycoprotein released from mature neutrophils and plasma concentration may increase immediately after STEMI. We therefore aimed to assess whether admission NGAL plasma concentration in patients with STEMI was associated with CS development after leaving the catheterization laboratory (late CS) and 30-day all-cause mortality.

PATIENTS AND METHODS: From 1,892 consecutive patients with STEMI 1,626 (86%) had plasma NGAL concentration measured upon hospital admission before angiography throughout a 1-year period at two tertiary heart centers in Denmark. Patients were stratified according to NGAL quartiles (Q1-4). To assess late CS development, we adjusted for the Observatoire Régional Breton sur l'Infarctus risk score for late CS. For mortality assessment, we adjusted for gender, age, post-PCI culprit Thrombolysis in myocardial infarction flow, left ventricular ejection fraction (LVEF), kidney dysfunction, and being comatose after cardiac arrest.

RESULTS: Increasing NGAL concentration was associated with higher age, more comorbidities, and more critical patient conditions including lower blood pressure and LVEF. When adjusted for factors associated with poor outcome, NGAL remained independently associated with both late CS development (Q4 vs. Q1-3) (OR (95% CI) 3.64 (1.79-7.41) and 30-day mortality (HR (95% CI) 3.18 (1.73-5.84)).

CONCLUSION: Admission plasma concentration of NGAL in STEMI patients is independently associated with 30-day all-cause mortality and predictive of late CS development.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Frydland M, Møgelvang R, Møller JE, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) Measured at Admission is Associated With Development of Late Cardiogenic Shock and Mortality in Patients With ST-Segment Elevation Myocardial Infarction. Shock. 2021. PMID: 34276039. doi:10.1097/SHK.0000000000001721

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。